JP2017508442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508442A5 JP2017508442A5 JP2016546862A JP2016546862A JP2017508442A5 JP 2017508442 A5 JP2017508442 A5 JP 2017508442A5 JP 2016546862 A JP2016546862 A JP 2016546862A JP 2016546862 A JP2016546862 A JP 2016546862A JP 2017508442 A5 JP2017508442 A5 JP 2017508442A5
- Authority
- JP
- Japan
- Prior art keywords
- genes listed
- derivative
- mdm2i
- salt
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 32
- 206010028980 Neoplasm Diseases 0.000 claims 16
- 238000000034 method Methods 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 201000011510 cancer Diseases 0.000 claims 8
- 108010016788 Cyclin-Dependent Kinase Inhibitor p21 Proteins 0.000 claims 7
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 claims 7
- 102100032500 40S ribosomal protein S27-like Human genes 0.000 claims 6
- 102100034150 Apoptosis-enhancing nuclease Human genes 0.000 claims 6
- 101000731896 Homo sapiens 40S ribosomal protein S27-like Proteins 0.000 claims 6
- 101000780559 Homo sapiens Apoptosis-enhancing nuclease Proteins 0.000 claims 6
- 101000928259 Homo sapiens NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 claims 6
- 102100036777 NADPH:adrenodoxin oxidoreductase, mitochondrial Human genes 0.000 claims 6
- 230000014509 gene expression Effects 0.000 claims 6
- 229940126062 Compound A Drugs 0.000 claims 5
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 230000004547 gene signature Effects 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 102100036413 2',5'-phosphodiesterase 12 Human genes 0.000 claims 4
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 claims 4
- 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 claims 4
- 102100021122 DNA damage-binding protein 2 Human genes 0.000 claims 4
- 102100035481 DNA polymerase eta Human genes 0.000 claims 4
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 claims 4
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 claims 4
- 102000016251 GREB1 Human genes 0.000 claims 4
- 108050004787 GREB1 Proteins 0.000 claims 4
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 claims 4
- 101001072024 Homo sapiens 2',5'-phosphodiesterase 12 Proteins 0.000 claims 4
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 claims 4
- 101001041466 Homo sapiens DNA damage-binding protein 2 Proteins 0.000 claims 4
- 101001094607 Homo sapiens DNA polymerase eta Proteins 0.000 claims 4
- 101000865085 Homo sapiens DNA polymerase theta Proteins 0.000 claims 4
- 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 claims 4
- 101001032502 Homo sapiens Iron-sulfur cluster assembly enzyme ISCU, mitochondrial Proteins 0.000 claims 4
- 101001033754 Homo sapiens Mediator of RNA polymerase II transcription subunit 31 Proteins 0.000 claims 4
- 101000574631 Homo sapiens Meteorin Proteins 0.000 claims 4
- 101000645266 Homo sapiens Mitochondrial import inner membrane translocase subunit Tim22 Proteins 0.000 claims 4
- 101000583714 Homo sapiens Pleckstrin homology-like domain family A member 3 Proteins 0.000 claims 4
- 101001105683 Homo sapiens Pre-mRNA-processing-splicing factor 8 Proteins 0.000 claims 4
- 101000842302 Homo sapiens Protein-cysteine N-palmitoyltransferase HHAT Proteins 0.000 claims 4
- 101000717450 Homo sapiens RCC1 and BTB domain-containing protein 1 Proteins 0.000 claims 4
- 101001061669 Homo sapiens Required for excision 1-B domain-containing protein Proteins 0.000 claims 4
- 101000929936 Homo sapiens Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 claims 4
- 101000618110 Homo sapiens Sperm-associated antigen 7 Proteins 0.000 claims 4
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims 4
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims 4
- 102100038096 Iron-sulfur cluster assembly enzyme ISCU, mitochondrial Human genes 0.000 claims 4
- 102100039122 Mediator of RNA polymerase II transcription subunit 31 Human genes 0.000 claims 4
- 102100025695 Meteorin Human genes 0.000 claims 4
- 102100026258 Mitochondrial import inner membrane translocase subunit Tim22 Human genes 0.000 claims 4
- 102100030925 Pleckstrin homology-like domain family A member 3 Human genes 0.000 claims 4
- 102100021231 Pre-mRNA-processing-splicing factor 8 Human genes 0.000 claims 4
- 102100030616 Protein-cysteine N-palmitoyltransferase HHAT Human genes 0.000 claims 4
- 102100020837 RCC1 and BTB domain-containing protein 1 Human genes 0.000 claims 4
- 102100028426 Required for excision 1-B domain-containing protein Human genes 0.000 claims 4
- 102100035766 Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 claims 4
- 102100021912 Sperm-associated antigen 7 Human genes 0.000 claims 4
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims 4
- NUKCQDDVORQLDB-OLILMLBXSA-N (3s)-4-[(1r)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3h-1,4-benzodiazepine-2,5-dione Chemical compound C1([C@@H]2N(C(C3=CC(I)=CC=C3N(CCCN3CCN(C)CC3)C2=O)=O)[C@H](C)C=2C(=CC(Cl)=CC=2)N)=CC=C(Cl)C=C1 NUKCQDDVORQLDB-OLILMLBXSA-N 0.000 claims 3
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical class C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 claims 3
- BDUHCSBCVGXTJM-WUFINQPMSA-N 4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone Chemical compound CC(C)OC1=CC(OC)=CC=C1C1=N[C@@H](C=2C=CC(Cl)=CC=2)[C@@H](C=2C=CC(Cl)=CC=2)N1C(=O)N1CC(=O)NCC1 BDUHCSBCVGXTJM-WUFINQPMSA-N 0.000 claims 3
- CLRSLRWKONPSRQ-IIPSPAQQSA-N C1([C@@H]2N(C(=O)CC=3C=C(C(=CC=32)OC(C)C)OC)C=2C=CC(=CC=2)N(C)C[C@@H]2CC[C@H](CC2)N2CC(=O)N(C)CC2)=CC=C(Cl)C=C1 Chemical compound C1([C@@H]2N(C(=O)CC=3C=C(C(=CC=32)OC(C)C)OC)C=2C=CC(=CC=2)N(C)C[C@@H]2CC[C@H](CC2)N2CC(=O)N(C)CC2)=CC=C(Cl)C=C1 CLRSLRWKONPSRQ-IIPSPAQQSA-N 0.000 claims 3
- 102100022477 DNA repair protein complementing XP-C cells Human genes 0.000 claims 3
- 101000618535 Homo sapiens DNA repair protein complementing XP-C cells Proteins 0.000 claims 3
- 101000836394 Homo sapiens Sestrin-1 Proteins 0.000 claims 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 3
- 102100027288 Sestrin-1 Human genes 0.000 claims 3
- QBGKPEROWUKSBK-QPPIDDCLSA-N [(4s,5r)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C(N([C@]1(C)C=2C=CC(Cl)=CC=2)C(=O)N2CCN(CCCS(C)(=O)=O)CC2)=N[C@@]1(C)C1=CC=C(Cl)C=C1 QBGKPEROWUKSBK-QPPIDDCLSA-N 0.000 claims 3
- 150000002475 indoles Chemical class 0.000 claims 3
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical class C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 claims 3
- 239000002853 nucleic acid probe Substances 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- VLJNHYLEOZPXFW-UHFFFAOYSA-N pyrrolidine-2-carboxamide Chemical class NC(=O)C1CCCN1 VLJNHYLEOZPXFW-UHFFFAOYSA-N 0.000 claims 3
- 150000004040 pyrrolidinones Chemical class 0.000 claims 3
- XOYCLJDJUKHHHS-LHBOOPKSSA-N (2s,3s,4s,5r,6r)-6-[[(2s,3s,5r)-3-amino-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@H](O2)C(O)=O)O)[C@@H](N)C1 XOYCLJDJUKHHHS-LHBOOPKSSA-N 0.000 claims 2
- 102100027308 Apoptosis regulator BAX Human genes 0.000 claims 2
- 108050006685 Apoptosis regulator BAX Proteins 0.000 claims 2
- 101150060120 C1qbp gene Proteins 0.000 claims 2
- 102100037078 Complement component 1 Q subcomponent-binding protein, mitochondrial Human genes 0.000 claims 2
- 102100022273 Disrupted in schizophrenia 1 protein Human genes 0.000 claims 2
- 101150061947 EIF2D gene Proteins 0.000 claims 2
- 102100021309 Elongation factor Ts, mitochondrial Human genes 0.000 claims 2
- 102100038075 Eukaryotic translation initiation factor 2D Human genes 0.000 claims 2
- 102100027681 Fructose-2,6-bisphosphatase TIGAR Human genes 0.000 claims 2
- 102100033506 G-rich sequence factor 1 Human genes 0.000 claims 2
- 102100040579 Guanidinoacetate N-methyltransferase Human genes 0.000 claims 2
- 101000902072 Homo sapiens Disrupted in schizophrenia 1 protein Proteins 0.000 claims 2
- 101000895350 Homo sapiens Elongation factor Ts, mitochondrial Proteins 0.000 claims 2
- 101000651314 Homo sapiens Fructose-2,6-bisphosphatase TIGAR Proteins 0.000 claims 2
- 101000870806 Homo sapiens G-rich sequence factor 1 Proteins 0.000 claims 2
- 101000893897 Homo sapiens Guanidinoacetate N-methyltransferase Proteins 0.000 claims 2
- 101000576989 Homo sapiens Mannose-P-dolichol utilization defect 1 protein Proteins 0.000 claims 2
- 101000701936 Homo sapiens Signal peptidase complex subunit 1 Proteins 0.000 claims 2
- 101000648224 Homo sapiens Syntaxin-8 Proteins 0.000 claims 2
- 101000795222 Homo sapiens TP53-regulated inhibitor of apoptosis 1 Proteins 0.000 claims 2
- 101000723893 Homo sapiens Zinc finger matrin-type protein 3 Proteins 0.000 claims 2
- 102100025297 Mannose-P-dolichol utilization defect 1 protein Human genes 0.000 claims 2
- 102100021769 Mitochondrial 2-oxoglutarate/malate carrier protein Human genes 0.000 claims 2
- 108091006417 SLC25A11 Proteins 0.000 claims 2
- 102100030313 Signal peptidase complex subunit 1 Human genes 0.000 claims 2
- 102100028808 Syntaxin-8 Human genes 0.000 claims 2
- 102100029669 TP53-regulated inhibitor of apoptosis 1 Human genes 0.000 claims 2
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 claims 2
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 claims 2
- 102100028482 Zinc finger matrin-type protein 3 Human genes 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 claims 1
- 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 claims 1
- 101150080074 TP53 gene Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 108700025694 p53 Genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461927310P | 2014-01-14 | 2014-01-14 | |
| US61/927,310 | 2014-01-14 | ||
| PCT/JP2015/051157 WO2015108175A1 (en) | 2014-01-14 | 2015-01-13 | Gene signatures associated with sensitivity to mdm2 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017508442A JP2017508442A (ja) | 2017-03-30 |
| JP2017508442A5 true JP2017508442A5 (enExample) | 2018-02-08 |
Family
ID=52432889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016546862A Pending JP2017508442A (ja) | 2014-01-14 | 2015-01-13 | Mdm2阻害剤に対する感受性と関連する遺伝子シグネチャー |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20160333419A1 (enExample) |
| EP (1) | EP3094746A1 (enExample) |
| JP (1) | JP2017508442A (enExample) |
| WO (1) | WO2015108175A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| CN104812384B (zh) | 2012-11-01 | 2020-09-18 | 爱勒让治疗公司 | 二取代的氨基酸及其制备和使用方法 |
| MX389354B (es) | 2014-09-24 | 2025-03-20 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y formulaciones de los mismos. |
| JP2017533889A (ja) | 2014-09-24 | 2017-11-16 | エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. | ペプチド模倣大環状分子およびその使用 |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| TWI804010B (zh) * | 2015-08-03 | 2023-06-01 | 瑞士商諾華公司 | 作為血液學毒性生物標記之gdf-15 |
| GB201517216D0 (en) | 2015-09-29 | 2015-11-11 | Cancer Res Technology Ltd And Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201517217D0 (en) | 2015-09-29 | 2015-11-11 | Astex Therapeutics Ltd And Cancer Res Technology Ltd | Pharmaceutical compounds |
| JP2018538247A (ja) | 2015-10-23 | 2018-12-27 | 第一三共株式会社 | Amlを処置することに用いるための医薬組成物およびそれを必要とする対象においてamlを処置する方法 |
| JP6855472B2 (ja) | 2015-10-23 | 2021-04-07 | 第一三共株式会社 | がんを治療するためのmdm2阻害剤の投与計画 |
| CN106512009B (zh) * | 2016-10-28 | 2019-10-11 | 武汉大学 | Ph同源域家族a成员3(phlda3)在治疗心肌肥厚中的应用 |
| GB201704965D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201704966D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| WO2020235671A1 (ja) * | 2019-05-23 | 2020-11-26 | 国立大学法人大阪大学 | 性ホルモン非感受性greb1陽性腫瘍の治療剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE045880T2 (hu) * | 2012-07-31 | 2020-01-28 | Novartis Ag | A humán double minute 2 (MDM2) inhibitorra való érzékenységgel összefüggõ markerek |
| CA2912547A1 (en) * | 2013-07-03 | 2015-01-08 | F. Hoffmann-La Roche Ag | Mrna-based gene expression for personalizing patient cancer therapy with an mdm2 antagonist |
-
2015
- 2015-01-13 EP EP15701594.2A patent/EP3094746A1/en not_active Withdrawn
- 2015-01-13 WO PCT/JP2015/051157 patent/WO2015108175A1/en not_active Ceased
- 2015-01-13 JP JP2016546862A patent/JP2017508442A/ja active Pending
- 2015-01-13 US US15/111,358 patent/US20160333419A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017508442A5 (enExample) | ||
| CN112930569B (zh) | 无细胞dna中的微卫星不稳定性检测 | |
| Degtyareva et al. | Regulatory SNPs: altered transcription factor binding sites implicated in complex traits and diseases | |
| Tuaeva et al. | Translational application of circulating DNA in oncology: review of the last decades achievements | |
| Schlauch et al. | Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome | |
| Desai et al. | Next‐generation sequencing: ready for the clinics? | |
| JP2013127477A5 (enExample) | ||
| Bonnefond et al. | Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing | |
| EP4574992A3 (en) | Combinatorial dna screening | |
| JP2017523810A5 (enExample) | ||
| Lin et al. | Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing | |
| Vos et al. | Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial | |
| Noviello et al. | Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial | |
| Vasli et al. | Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders | |
| JP2017512491A5 (enExample) | ||
| JP2016000057A5 (enExample) | ||
| JP2012501452A5 (enExample) | ||
| JP2017532959A5 (enExample) | ||
| Millat et al. | Evaluation of a new high-throughput next-generation sequencing method based on a custom AmpliSeq™ library and ion torrent PGM™ sequencing for the rapid detection of genetic variations in long QT syndrome | |
| JP2011528903A5 (enExample) | ||
| JP2025026905A (ja) | ヒト腫瘍のがん細胞における分子活性を定量化するための方法 | |
| JP2017509351A5 (enExample) | ||
| Caberlotto et al. | Systems biology meets-omic technologies: novel approaches to biomarker discovery and companion diagnostic development | |
| RU2009127735A (ru) | Определение предрасположенности к раку путем идентификации генотипических комбинаций специфичных вариантов генов cyp1b1, brca2 и снек2 | |
| JP2012120540A5 (ja) | 遺伝子発現プロファイルによる胃癌の検出 |